The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. III. Pitfalls in diagnosis.

Acta cytologica · 1988 · vol. 32(3) , pp. 325–30 · PMID:3376699 · W187255373
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-07

This paper presents three cases of benign cervical lesions misdiagnosed as adenocarcinoma in situ, highlighting diagnostic pitfalls and discussing the differential diagnosis of endocervical glandular abnormalities.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Potential pitfalls in the cytologic diagnosis of adenocarcinoma in situ (AIS) of the cervix are illustrated by the presentation of three cases of benign cervical lesions initially diagnosed as AIS: cervical endometriosis, tubal metaplasia of the endocervix and changes due to a previous biopsy. The differential diagnosis of endocervical glandular abnormalities is discussed.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Adenocarcinoma Carcinoma in Situ Uterine Cervical Neoplasms Adenocarcinoma Adenocarcinoma Adult Carcinoma in Situ Carcinoma in Situ Diagnosis, Differential Diagnostic Errors Endometriosis Endometriosis Endometriosis Female Humans Middle Aged Uterine Cervical Neoplasms Uterine Cervical Neoplasms Vaginal Smears

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:20.810540+00:00
License: CC0 · commercial use OK